In the case of patients with kidney disease, they could have overexpression of the transporter in the kidney if there are no mutations present; however, a longitudinal study is needed that considers uric acid levels, renal dysfunction, and the treatment of each patient to compare the expression of SLC22A12 in these cases [45]. The gene discussed is SLC22A12; the disease is kidney disorder.